CVS Health Corp operates in the Drug stores and proprietary stores sector. In addition to historical fundamental analyses, the complete report available to purchase compares CVS Health Corp with three other drug stores in North America: McKesson Corporation (2019 sales of $214.32 billion of which 78% was U.S. Pharmaceutical and Specialty Soluti), AmerisourceBergen Corporation ($179.59 billion of which 96% was Pharmaceutical Distribution), and Cardinal Health, Inc. ($145.53 billion of which 89% was Pharmaceutical).

Sales Analysis. CVS Health Corp reported sales of $256.78 billion for the year ending December of 2019. This represents an increase of 32.0% versus 2018, when the company's sales were $194.58 billion. Sales at CVS Health Corp have increased during each of the previous five years (and since 2014, sales have increased a total of 84%). Sales of Healthcare Benefits saw an increase that was more than double the company's growth rate: sales were up 1,154.4% in 2019, from $5.55 billion to $69.60 billion. Not all segments of CVS Health Corp experienced an increase in sales in 2019: sales of Corporate Segment fell 15.5% to $512.00 million. (However, this segment's sales were only a very small portion of the company's overall sales).